Financial Highlights for the Three Months Ended September 30, 2015 Compared to the Three Months Ended September 30, 2014 (unaudited):

Net revenue of $11.4 million as compared to $11.7 million in the comparable period of 2014. The prior period results benefited from revenue of $5.4 million received from the Centers for Medicare and Medicaid Services ("CMS") under the Medicare Shared Savings Program.

Loss from operations of $413,000 compared to income from operations of $1.86 million in the comparable period of 2014. The prior year period benefited from $5.4 million received from CMS under the Medicare Shared Savings Program.

On September 30, 2015, the Company had total assets of $13.6 million, including cash and cash equivalents of $3.9 million

Financial Highlights for the Six Months Ended September 30, 2015 Compared to the Six Months Ended September 30, 2014 (unaudited):

Net revenue of $21.6 million compared to $15.8 million in the comparable prior year period, an increase of 37%.

Loss from operations of $2.1 million compared to income of $672,000.

Sequential Financial Highlights for the Three Months Ended September 30, 2015 Compared to the Three Months Ended June 30, 2015 (unaudited):

Net revenue of $11.4 million, an increase of 11% from $10.2 million in prior quarter period of 2015, attributable to the growth of Maverick Medical Group and Apollo Palliative Services.

Loss from operations of $413,000 compared to a loss of $1.7 million in prior quarter period of 2015, attributable to continued cost efficiency measures within the company.

"We are pleased with our third consecutive quarter of sequential revenue growth. Our quarterly revenue has increased sequentially from $7.6 million for the three months ended December 31, 2014 to $11.4 million for the three months ended September 30, 2015," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings. "Additionally, on October 14, 2015 we secured a strategic investment of $10 million from Network Medical Management, Inc. which strengthened our balance sheet and positions us well for continued growth."

For more details on ApolloMed's 2016 fiscal year second quarter results, please refer to the Company's 10-Q filed with the U.S. Securities Exchange Commission and accessible at www.sec.gov.

Forward Looking StatementsThis press release may contain forward-looking statements, including information about management's view of Apollo Medical Holdings, Inc. ("the Company") future expectations, plans and prospects. In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this press release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of the Company, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. Some factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the Company's Annual Report on our amended Form 10-K for the fiscal year ended March 31, 2015, under the caption "Risk Factors", which is on file with the Securities and Exchange Commission and available in the "Investor" section of the Company's website under the heading "SEC Filings". The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by Apollo Medical Holdings, Inc.